University of Pavia

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Established: 1361-01-01

Employees: 1K

Market Cap: -

Website: http://www.unipv.it

Clinical Trials

Nutraceutical on Hyperuricemia

Phase 4

Completed

Conditions: Hyperuricemia

Interventions: Drug: Uricemin
Drug: Placebo

First Posted Date: 2019-11-13

Last Posted Date: 2020-11-10

Lead Sponsor: University of Pavia

Target Recruit Count: 116

Registration Number: NCT04161872

Locations: 🇮🇹
IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy

Shaping Microbiome in the First 1,000 Days of Life

Completed

Conditions: Microbial Colonization

First Posted Date: 2019-10-10

Last Posted Date: 2019-10-10

Lead Sponsor: University of Pavia

Target Recruit Count: 60

Registration Number: NCT04122612

Locations: 🇮🇹
IRCCSSMP, Pavia, Italy

Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients With Fasting Dysglycemia

Phase 3

Completed

Conditions: Dysglycemia

Interventions: Other: Placebo
Dietary Supplement: Reglicem

First Posted Date: 2019-09-27

Last Posted Date: 2019-10-02

Lead Sponsor: University of Pavia

Target Recruit Count: 148

Registration Number: NCT04107987

Locations: 🇮🇹
IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy

Nutraceutical on Hyperglycemia

Phase 3

Completed

Conditions: Dysglycemia

Interventions: Other: Placebo
Dietary Supplement: Glicoset

First Posted Date: 2019-09-27

Last Posted Date: 2019-10-01

Lead Sponsor: University of Pavia

Target Recruit Count: 148

Registration Number: NCT04107922

Locations: 🇮🇹
IRCCS Policlinico San Matteo, Pavia, Lombardy, Italy

Outcome Study in Refractory Epilepsy (SOPHIE)

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Other: AEP score available to the treating physician

First Posted Date: 2019-05-06

Last Posted Date: 2019-05-06

Lead Sponsor: University of Pavia

Target Recruit Count: 1000

Registration Number: NCT03939507

Locations: 🇮🇹
Clinical Pharmacology Unit, University of Pavia, Pavia, Italy

Use of Incretins in Diabetic Patients

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: DPP-4 inhibitors

First Posted Date: 2018-04-03

Last Posted Date: 2022-05-24

Lead Sponsor: University of Pavia

Target Recruit Count: 2234

Registration Number: NCT03486964

Locations: 🇮🇹
IRCCS Policlinico San Matteo Foundation, Pavia, Lombardy, Italy

Creatine, D-Ribose, B1 Vitamin, and B6 Vitamin in Ischemic Heart Disease

Not Applicable

Completed

Conditions: Ischemic Heart Disease

Interventions: Other: Placebo
Dietary Supplement: Creatine, D-Ribose, B1 Vitamin, and B6 vitamin

First Posted Date: 2018-01-26

Last Posted Date: 2018-01-31

Lead Sponsor: University of Pavia

Target Recruit Count: 55

Registration Number: NCT03411369

Insulin Pump vs Multiple Daily Injection on Cardiovascular Outcomes (ITALICO)

Completed

Conditions: Diabetes Mellitus

Interventions: Device: CSII

First Posted Date: 2017-11-09

Last Posted Date: 2017-11-09

Lead Sponsor: University of Pavia

Target Recruit Count: 215

Registration Number: NCT03338439

Locations: 🇮🇹
IRCCS Policlinico San Matteo Foundation, Pavia, PV, Italy

Instrumental or Physical-Exercise Rehabilitation of Balance in Parkinson's Disease? (IPER-PD)

Not Applicable

Completed

Conditions: Parkinson's Disease
Rehabilitation

Interventions: Other: Balance exercise
Other: Mobile platform exercise

First Posted Date: 2017-10-19

Last Posted Date: 2017-10-19

Lead Sponsor: University of Pavia

Target Recruit Count: 38

Registration Number: NCT03314597

Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)

Completed

Conditions: Cardiac Heart Failure Patients

Interventions: Drug: Canrenone

First Posted Date: 2017-08-28

Last Posted Date: 2018-02-05

Lead Sponsor: University of Pavia

Target Recruit Count: 502

Registration Number: NCT03263962

Locations: 🇮🇹
IRCCS Policlinico San Matteo, Pavia, Italy

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy